80 results
Page 3 of 4
8-K
EX-99.1
glsijqohtni
10 Aug 20
Sage Therapeutics Announces Second Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
7:00am
8-K
EX-99.1
flpg5z0 26t9t1
7 May 20
Sage Therapeutics Announces First Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
4:27pm
8-K
EX-99.1
j8g hihw6ri
7 Apr 20
Sage Therapeutics Announces Restructuring to Advance Corporate Strategy and Pipeline
4:25pm
8-K
EX-99.1
epdbbj
18 Mar 20
Sage Therapeutics Announces Development Plan for Zuranolone(SAGE-217) Following
6:57am
8-K
EX-99.1
xooft
27 Feb 20
Sage Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
EX-99.1
899401
12 Nov 19
Sage Therapeutics Announces Third Quarter 2019 Financial Results and Highlights
6:44am
8-K
EX-99.1
an7ahsf47k73d we2hob
6 Aug 19
Results of Operations and Financial Condition
7:04am
8-K
EX-99.1
gfj uzycm
24 Jul 19
Sage Therapeutics Announces Clinical Updates and Progress Across Neuroscience Pipeline
7:18am
8-K
EX-99.1
vabtfhuts
14 Jun 19
Sage Therapeutics Announces U.S. Drug Enforcement Administration Scheduling of ZULRESSOâ„¢ (brexanolone) Injection
9:03am
8-K
EX-99.1
2reht7are71u83a
2 May 19
Sage Therapeutics Announces First Quarter 2019 Financial Results and Highlights Pipeline and Business Progress
7:25am
8-K
EX-99.1
5760h
19 Mar 19
Other Events
9:08pm
424B5
i0cnkfv19umnv wr0x7a
27 Feb 19
Prospectus supplement for primary offering
8:04am
424B5
3fyv41a6lfc3zcnv
25 Feb 19
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.2
oa7a0ddqfuq2yw
7 Jan 19
Regulation FD Disclosure
7:30am